Publication | Closed Access

Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems

Surgical Oncology15-Year StudyMedicineIntravenous BisphosphonatesOncologyRadiation OncologyOsteoporosisRadiologyHealth Sciences